Mutational analysis of glycosylation, membrane translocation, and cell surface expression of the hepatitis E virus ORF2 protein.
about
The open reading frame 3 gene of hepatitis E virus contains a cis-reactive element and encodes a protein required for infection of macaquesStructure of the hepatitis E virus-like particle suggests mechanisms for virus assembly and receptor bindingA C-terminal Hydrophobic Region is Required for Homo-Oligomerization of the Hepatitis E Virus Capsid (ORF2) ProteinBiological and immunological characteristics of hepatitis E virus-like particles based on the crystal structureMolecular Biology and Infection of Hepatitis E VirusMutations within potential glycosylation sites in the capsid protein of hepatitis E virus prevent the formation of infectious virus particles.Capped RNA transcripts of full-length cDNA clones of swine hepatitis E virus are replication competent when transfected into Huh7 cells and infectious when intrahepatically inoculated into pigs.NTPase and 5' to 3' RNA duplex-unwinding activities of the hepatitis E virus helicase domain.The in vitro-synthesized RNA from a cDNA clone of hepatitis E virus is infectious.Zoonotic hepatitis E: animal reservoirs and emerging risksVirus-specific mRNA capping enzyme encoded by hepatitis E virusHepatitis E virus ORF2 protein activates the pro-apoptotic gene CHOP and anti-apoptotic heat shock proteinsMolecular virology of hepatitis E virus.The ORF2 glycoprotein of hepatitis E virus inhibits cellular NF-κB activity by blocking ubiquitination mediated proteasomal degradation of IκBα in human hepatoma cells.Hepatitis E: an overview and recent advances in vaccine research.Novel hepatitis E like virus found in Swedish mooseThree amino acid mutations (F51L, T59A, and S390L) in the capsid protein of the hepatitis E virus collectively contribute to virus attenuation.ORF3 protein of hepatitis E virus is not required for replication, virion assembly, or infection of hepatoma cells in vitro.Hepatitis E Virus Produced from Cell Culture Has a Lipid Envelope.Hepatitis E virus replication requires an active ubiquitin-proteasome system.Characterization of hepatitis E virus recombinant ORF2 proteins expressed by vaccinia viruses.The hepatitis E virus Orf3 protein protects cells from mitochondrial depolarization and death.The hepatitis E virus open reading frame 3 protein activates ERK through binding and inhibition of the MAPK phosphataseThe hepatitis E virus ORF3 protein modulates epidermal growth factor receptor trafficking, STAT3 translocation, and the acute-phase response.Identification of critical residues in Hepatitis E virus macro domain involved in its interaction with viral methyltransferase and ORF3 proteins.Opportunistic intruders: how viruses orchestrate ER functions to infect cells.In vitro and in vivo mutational analysis of the 3'-terminal regions of hepatitis e virus genomes and repliconsHeparan sulfate proteoglycans are required for cellular binding of the hepatitis E virus ORF2 capsid protein and for viral infection.Cytoplasmic localization of the ORF2 protein of hepatitis E virus is dependent on its ability to undergo retrotranslocation from the endoplasmic reticulum.Peek-a-boo: membrane hijacking and the pathogenesis of viral hepatitisExpression and processing of the Hepatitis E virus ORF1 nonstructural polyprotein.Determination of the full-genome sequence of hepatitis E virus (HEV) SAAS-FX17 and use as a reference to identify putative HEV genotype 4 virulence determinants.Hepatitis E Virus (HEV) egress: Role of BST2 (Tetherin) and interferon induced long non- coding RNA (lncRNA) BISPR.Origin, antigenicity, and function of a secreted form of ORF2 in hepatitis E virus infection.Hepatitis E in High-Income Countries: What Do We Know? And What Are the Knowledge Gaps?
P2860
Q24524173-512B0E9D-7030-4FAF-8014-E5B65F773B2FQ24655874-6AD6F149-623F-43C8-A1CD-7F9B7AD165D9Q24806456-02EC98E3-AC34-4493-8232-11B568D7F312Q27646563-48574BBB-EDC4-4C57-988F-CB582A6B2760Q28066101-98D2F8BF-5D9C-4053-B3A5-5C03082B5BCEQ30366046-D21714DC-7E54-4676-BE66-1C390270294EQ33716547-7A238293-F8DD-4432-BAE1-870D4553E59FQ33725552-197A31B9-0C8F-455C-9DDA-C2685820AC48Q33799230-1DF1A28F-E42C-4997-8F02-0F0AFFCA7940Q33832118-317F9142-E0F7-4DD7-BF34-83B2B0157EE8Q33842747-566E6D07-13D7-4B28-AB00-CA88D1B35503Q34038276-D3CCE188-589A-43D9-81A1-8D168BDD914CQ34166393-C4BF7396-5EFE-4E1D-8E28-9E798EC6E69FQ34271313-7B2E05CD-925C-4728-817C-2F69FE9DEB3DQ34334086-5EF0B1DD-8E8D-4ACB-8C27-EEAEF0B84892Q34389256-42B372FF-DCB3-4F69-BAE3-4B7E04C21C09Q34982710-561217D0-0D7B-4F55-8584-837996E9580BQ35139263-F69F0419-FCD1-4AF0-BF25-AC27CA352AA2Q35687869-DBFA813B-FA61-470E-A72D-F6FF98397070Q35943360-AE8834B2-D0CF-4BAB-AB08-3D83421356C2Q36171812-6F07452B-AAD5-4B9D-909D-7321B84D70B9Q36738014-93248B53-FAF8-4B46-AC1B-555714711F07Q36739811-CD4214D8-71E5-4D3A-A158-97B960B2A16DQ36747760-EEB1189E-55A5-4DD3-84C5-959790226B4BQ36835433-8DBFD0C9-3AFA-4F3B-8B62-EDBA00086684Q37610842-3400F940-2AAA-416B-85C0-095FAF8E40D3Q37742786-7E4E8CAF-7C55-4105-8777-2461A738C4B6Q39790232-E4E12FD2-0460-4EB4-A8D8-8CBDA0FE5BCAQ40182274-5B7BAFE5-D616-4BC7-B42E-651068BC9F41Q41847633-78A06FC7-0A16-4899-8112-A30478A4E375Q41948798-AC25F85A-967A-45FD-AA80-AFCAA8953FE1Q41998713-F7D2377C-0213-46A6-8463-00CFFB615251Q45325421-2511C825-CF47-4773-88CD-C71455E07451Q52579672-B4C22F47-5A39-4D20-A0F6-B12A316B3DD6Q56000615-71E792EE-4F9A-46EF-B773-08F03403F843
P2860
Mutational analysis of glycosylation, membrane translocation, and cell surface expression of the hepatitis E virus ORF2 protein.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Mutational analysis of glycosy ...... epatitis E virus ORF2 protein.
@en
Mutational analysis of glycosy ...... epatitis E virus ORF2 protein.
@nl
type
label
Mutational analysis of glycosy ...... epatitis E virus ORF2 protein.
@en
Mutational analysis of glycosy ...... epatitis E virus ORF2 protein.
@nl
prefLabel
Mutational analysis of glycosy ...... epatitis E virus ORF2 protein.
@en
Mutational analysis of glycosy ...... epatitis E virus ORF2 protein.
@nl
P2093
P2860
P1433
P1476
Mutational analysis of glycosy ...... hepatitis E virus ORF2 protein
@en
P2093
P2860
P304
P407
P577
1999-05-01T00:00:00Z